Registered clinical trials investigating ketamine for psychiatric disorders
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 127, 1-12
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
- Bristol-Myers Squibb
- Janssen-Ortho
- Eli Lily
- Forest
- Lundbeck
- Pfizer
- Shire
- Merck
- Sepracor
- Otsuka
This publication has 27 references indexed in Scilit:
- Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain TherapyClinical Pharmacokinetics, 2016
- Single-dose infusion ketamine and non-ketamineN-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectoriesPsychological Medicine, 2016
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in DepressionAmerican Journal of Psychiatry, 2015
- Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress DisorderJAMA Psychiatry, 2014
- Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-ConceptNeuropsychopharmacology, 2013
- Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings)CNS Neuroscience & Therapeutics, 2013
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On TrialBiological Psychiatry, 2012
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar DepressionArchives of General Psychiatry, 2010
- A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major DepressionArchives of General Psychiatry, 2006
- KETAMINE AS AN INDUCTION AGENT IN ANÆSTHETICSThe Lancet, 1970